SCHEMBL21608571

SCHEMBL21608571

N#Cc1cnc(Br)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11392753 0.71
SCHEMBL22667090 0.67
SCHEMBL22275385 0.67 PDE4A (0.42)
SCHEMBL16995203 0.67
SCHEMBL2074108 0.66
SCHEMBL27351230 0.64 PDE4A (0.40)
SCHEMBL19806345 0.64 PDE4A (0.40)
SCHEMBL16608603 0.62 CHEK1 (0.36)
SCHEMBL27344638 0.62 ALDH1A1 (0.49)
SCHEMBL11392877 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107683282-A New URAT1 inhibitor and its application in medicine 江苏新元素医药科技有限公司 2018-02-09 CN claimed
US-20250136606-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2025-05-01 US disclosed
EP-4408850-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2024-08-07 EP disclosed
CN-118317963-A TRPML modulators, compositions thereof, and methods of use 卡拉韦治疗公司 2024-07-09 CN disclosed
WO-2023055920-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2023-04-06 WO disclosed
US-20210277003-A1 OGA INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-09-09 US disclosed
WO-2019243535-A1 OGA INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2019-12-26 WO disclosed
CN-107683282-A New URAT1 inhibitor and its application in medicine 江苏新元素医药科技有限公司 2018-02-09 CN disclosed